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COMMUNICATION 
In vitro reconstitution of formylglycine generating enzymes 
requires copper (I) 
 Matthias Knop,[a] Pascal Engi,[a] Roxana Lemnaru[a] and Florian P. Seebeck[a]* 
Abstract: Formylglycine generating enzymes (FGE) catalyze O2-
dependent conversion of specific cysteine residues of 
arylsulfatases and alkaline phosphatases to formylglycine. The 
ability to introduce unique aldehyde functions also into 
recombinant proteins makes FGE a powerful tool for protein 
engineering. One limitation of this technology is poor in vitro 
activity of reconstituted FGE. Although FGE has been 
characterized as a cofactor-free enzyme we report that one 
equivalent of Cu (I) increases catalytic efficiency by more than 
20-fold and unmasks stereoselective C-H bond cleavage at the
substrate as the rate-limiting step. These findings remove
previous limitations of FGE-based protein engineering and also
pose new questions about the catalytic mechanism of this O2-
utilizing enzyme.
The formylglycine generating enzyme (FGE) catalyzes O2-
dependent conversion of cysteine residues within a specific 
peptide motif to formylglycine (fGly, Figure 1).[1] This post-
translational modification occurs in the maturation of 
arylsulfatases and some alkaline phosphatases that use the 
hydrated form of fGly as catalytic nucleophile.[2] Insufficient 
FGE activity in human cells causes multiple sulfatase 
deficiency, which is a rare but fatal disease.[2a, 3] FGE has 
also become a promising tool in biotechnology,[4] allowing 
fGly introduction in virtually any recombinant protein provided 
that a FGE recognition motif is accessible.[5] Genetically 
encoded aldehyde tags provide excellent handles for 
selective protein modification.[1, 4a-d, 6] Published protocols for 
the production of aldehyde bearing proteins recommend co-
production of FGE with the protein of interest to achieve 
efficient insertion of fGly in vivo.[4b] The possibility to modify 
purified proteins in vitro would certainly broaden the scope of 
this technology, but was so far limited by the modest activity 
of reconstituted FGEs.[5]  
Possible reasons for low in vitro activity could be incomplete 
reconstitution of FGE caused by a missing partner enzyme, a 
missing cofactor or a missing posttranslational modification. 
These possibilities are difficult to evaluate because the 
catalytic activity of FGE is poorly understood. Several crystal 
structures of human and bacterial FGEs provide a detailed 
picture of the active site consisting of a peptide binding 
groove, a likely O2 binding site, and a pair of cysteine 
residues that are essential for catalysis.[1a, 3a, 7] Surprisingly, 
none of the structures contained any cofactor that would 
explain ability of FGE to utilize O2 as electron acceptor. 
Although cofactor-independent oxidases are known,  
Figure 1. Reaction scheme for FGE catalyzed O2-dependent formation of 
formylglycine (fGly). FGE removes the (R)-β-hydrogen atom (red) from the 
substrate, oxidizes one equivalent of DTT and produces one equivalent of 
H2S. 
they usually exploit their electron rich substrates to activate 
O2 by one-electron transfer.[8] In contrast, O2 activation by 
naked polypeptides such as FGE and its peptide substrate 
would be unprecedented. Therefor we suspected that the 
crystallized FGEs may not present the complete catalytic 
principle.  
In this report we show that addition of one equivalent of Cu (I) 
to FGE from Thermomonospora curvata  or Mycobacterium 
smegmatis increases catalytic efficiency by 20-fold. In 
presence of copper FGE displays a significant substrate 
kinetic isotope effect (KIE), suggesting that stereoselective C-
H bond cleavage from the substrate is at least partially rate 
limiting. Four point mutations increase this activity by an 
additional 10-fold. The overall 200-fold improvement should 
eliminate previous limitations of FGE as a tool for in vitro 
protein engineering.  
To establish a robust study system, we cloned and produced 
FGE from T. curvata (FGEwt). Production in Escherichia coli 
yielded up to 10 mg of purified FGE per culture liter. Owing to 
its thermophilic origin, this enzyme shows no sign of thermal 
unfolding up to 50°C (Figure S1).[3a, 3b] We quantified FGE 
activity using a nonapeptide (sequence: Abz-SALCSPTRA-
NH2) that includes the FGE substrate motif and a N-terminal 
ortho-amino benzoic acid (Abz) as chromophore. The fGly-
containing product was identified by ESI-MS and quantified 
by HPLC (Figure S2). In a reaction buffer containing 50 mM 
EDTA, 2 mM DTT, 50 mM NaCl and 50 mM Tris-HCl at pH 
8.0 the catalytic efficiency (kcat/KM) of FGE amounted to 100 
M-1min-1. This corresponds to less than one turnover per hour
in presence of 100 uM substrate. We could not estimate the
maximal velocity because no saturation occurred up to a
substrate concentration of 1 mM (Figure S3).
In pursuit of a more active catalyst, we examined three
potential problems that may limit the activity of reconstituted
FGE. First, we tested whether the enzyme may have been
damaged during purification. We were particularly concerned
about the two active site cysteines which may be sensitive to
irreversible oxidation.[7]
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FGEwt n.a 100 ± 50 0.8 ± 0.3 
FGEwt + Cu 1.6 ± 0.1 2900 ± 50 3.7 ± 0.1 
FGE4C 0.6 ± 0.1 1000 ± 200 1.2 ± 0.2 
FGE4C + Cu 4.2 ± 0.5 20000 ± 4000 3.0 ± 0.2 
 
[a] FGE activities were assayed at 25°C in reactions 
containing 2 uM enzyme, 5 mM DTT, 50 mM EDTA, 50 mM 
NaCl and 50 mM Tris-HCl pH 8.0, in presence or absence of 
2 µM of CuSO4. Product formation was monitored by HPLC. 
 
 
To determine the redox status of these two cysteine residues 
we constructed a FGE variant in which all cysteines outside 
the active site were mutated to either Ala or Ser 
(FGEC187A,C231A,C284S, C298A = FGE4C) (Figure S1). The resulting 
variant is still a stable protein (Figure S1B). More surprisingly, 
this enzyme is a 10-fold more efficient catalyst than the wild 
type enzyme and displays saturation behavior, characterized 
by a KM of 0.6 mM (Table 1). Evidently, only the two active 
site cysteines are essential for catalysis. Three of the mutated 
cysteines are either strictly (Cys298) or highly conserved 
(Cys187 and Cys231) among FGEs (Figure S1), suggesting 
that these residues might enhance or regulate activity in vivo, 
but are  obsolete in vitro. 
Using two complementary assay based on the Ellman’s 
reagent[9] we determined that the two remaining cysteine are 
predominantly oxidized to a disulfide in purified FGE4C (Table 
S1). Consistently, the mass of FGE4C as inferred by ESI-MS 
analysis proved 2 Da lighter than the calculated mass (Table 
S2). Furthermore, FGE4C resisted alkylation by the thiol 
specific electrophile iodoacetamide, but in presence of 2 mM 
DTT the enzyme readily reacted to the bis-alkylated form 
(Table S2). Drawn together these observations suggest that 
purified FGE4C contains a DTT reducible disulfide bond in the 
active site and that oxidative damage is not limiting in vitro 
activity of recombinant FGE4C. 
A second explanation for low in vitro activity could be the 
absence of a required co-substrate. While FGE definitely 
uses O2 to remove two electrons from the substrate,[7b] it is 
not entirely clear what happens to the resulting partially 
reduced oxygen species.[1a] The enzyme may either release 
hydrogen peroxide, or may further reduce the oxygen species 
to water using two additional electrons from an auxiliary 
reducing agent. The reported observation that in vitro activity 
of FGEhuman depends on DTT is consistent with the second 
scenario. [3a, 7a, 10] To address this question on a quantitative 
basis we measured the rates of FGE catalyzed  peptide 
modification, DTT oxidation, and H2S formation (Figure S4 & 
S5). This analysis revealed that the three reactions are 
coupled indicating that FGE depends on an external electron 
donor such as DTT and that the sulfur atom on the substrate 
is not oxidized in the reaction cycle.[1a]  
In absence of DTT FGE catalysis is 50-fold slower, indicating 
that the thiol containing substrate is a poor electron source  
 
  
Figure 2. Left: FGE4C activity as a function of [DTT] in presence () and 
absence () of Cu (I). Reactions contained 200 µM substrate, 0.2 – 4 mM 
DTT, 50 mM EDTA, 50 mM NaCl and 50 mM Tris-HCl pH 8.0. Product 
formation was monitored by HPLC. Right: A 50 uM solution of a 
chromogenic complex (ε562 = 7900 cm-1M-1) containing Cu (I) and 
bicinchoninic acid (BCA) was titrated with DTT, FGE4C or bovine serum 
albumin (BSA). The competition for Cu (I) between BCA and the titrant was 
monitored by UV/Vis-spectroscopy. 
 
 (Figure S6). Addition of 2 mM of DTT or cysteamine to this 
slow reaction immediately restored full activity. In contrast, 
addition of glutathione or tris(2-carboxyethyl)-phosphine 
(TCEP) recovered less than 2 % of the DTT supported 
activity suggesting that FGE displays selectivity for the 
reducing agent which is not necessarily correlated with their 
redox potential. FGE4C activity saturated at a DTT 
concentration well below 1 mM (Figure 2), indicating that 
availability of reducing equivalents should not be a limiting 
factor for in vitro activity. 
A third reason for low activity of reconstituted FGE may be 
the absence of an additional redox catalyst – despite previous 
characterizations of FGE as a cofactor-independent 
enzyme.[3a, 7b, 8b] In a screen for possible candidates we 
observed that addition of CuSO4 or CuBr to FGE4C and FGEwt 
increases the catalytic efficiency by over 20-fold (Table 1). In 
reactions containing 0.5-10 uM FGE4C this activating effect 
depends on precisely one equivalent of copper (Figure S7). 
Other metal salts containing Mn, Fe, Co, Ni, Zn, Cd, Ag, Pd, 
Hg or Ca did not accelerate the reaction (Figure S8). The 
specificity for copper suggests that FGE activation is due to 
the redox activity rather than the Lewis acidity of this metal. 
Hence, our search for an efficient in vitro FGE catalyst 
resulted in the surprising proposition that FGE from T. curvata 
may be a copper-dependent enzyme.  
To test whether copper-dependence is a capricious property 
of this particular homolog we also cloned and produced FGE 
from Mycobacterium smegmatis (FGEsmegmatis). Although the 
two organisms are both actinobacteria, their FGEs map to 
opposite branches of an unrooted phylogenetic tree of FGE 
homologs (Figure S9). In fact FGEwt is more related to 
FGEhuman (58 % sequence identity) than to FGEsmegmatis (46 %). 
Still, FGEsmegmatis shows similar copper-dependent activation 
as FGE4C or FGEwt (Figure S10). In this light it seems 
surprising that FGEhuman should be inhibited by micromolar  
copper concentrations as stated in an earlier report.[10] 
To understand the mechanism of activation in more detail we 
characterized the kinetic properties of copper supplemented 
FGE. Michaelis-Menten kinetics showed that copper 







































































increasing kcat (Table 1, Figure S3). Copper also accelerated  
catalysis by FGEwt and induced saturation behavior (Table 1). 
We also assayed FGE4C and FGEwt with a substrate analog in 
which the (R)-β-proton on the cysteine residue was replaced 
with a deuteron (in red, Figure 1). The deuterated and non-
deuterated substrates were converted to products with 
identical mass and isotope distribution (Figure S11), 
indicating that FGE specifically removes the (R)-β-hydrogen 
atom. In presence of copper both FGE4C and FGEwt show a 
significantly larger substrate KIE than in absence of copper 
(Table 1). These KIEs proved independent of substrate 
concentration (Figure S12). We therefor conclude that copper 
increases the extent to which C-H bond cleavage is rate 
limiting.  
The dramatic effects of copper on the catalytic properties of 
FGEwt and FGE4C certainly raise doubts as to whether FGE 
should be characterized as a cofactor-independent 
enzyme.[1a, 3a, 7b, 8b] On the other hand we do not think that 
FGE is bona fide copper-enzyme either. Although copper 
would provide an excellent cofactor for O2 activation, we were 
puzzled by the fact that DTT did not inhibit Cu (I) supported 
FGE activity. DTT is an strong ligand for Cu (I) (KD,Cu(I) = 10-15 
M) and only few specialized proteins can form stable copper 
complexes in presence of this artificial dithiol.[11] A qualitative 
experiment using a chromogenic Cu (I) complex that was 
titrated with DTT, FGE4C, bovine serum albumin (BSA) or 
green fluorescent protein (Figures 2 & S13) showed that the 
three proteins are a much weaker Cu (I) binder than DTT.[11] 
Consequently, 1 uM FGE and 1 uM Cu (I) can hardly form a 
stable complex in presence of 1 mM DTT. The observation 
that Cu (I) supported FGE catalysis is accelerated and not 
inhibited by increasing DTT concentration (Figure 2) further 
discredits the idea of a FGE:Cu (I) complex as the catalytic 
species. Cysteamine, which is also a strong Cu (I) ligand 
supports FGE activity to a similar extent as DTT (Figure S14).  
The requirement for millimolar concentrations of DTT or 
cysteamine may point an alternative role of Cu (I). The binary 
complex between Cu (I) and DTT forms at femtomolar 
concentration.[11] In contrast, ternary Cu (I) complexes 
comprising two ligands such as DTT or cysteamine are 
significantly less stable and only form at millimolar ligand 
concentrations.[12] Once formed these electron rich species 
[Cu (I)-(DTT)2]- could serve as a single-electron donor to 
activate FGE bound O2. The previous observation that Cu (I) 
in presence of 0.9 mM glutathione can reduce dissolved O2 to 
superoxide,[13] provides good precedence for this idea. 
Although such low molecular weight Cu (I)-thiol complexes 
are improbable species in a cellular context,[14] it seems 
possible that in vivo FGE activity  may depend on single-
electron donors such as flavodoxins,  cytochromes or  iron-
sulfur proteins.[15] 
Residual in vitro FGE activity in absence of Cu (I) is probably 
caused by the significant level of reactive oxygen species 
present in any buffered aqueous system. For example, in our 
standart reaction buffer containing 50 mM Tris-HCl at pH 8.0, 
50 mM EDTA, 2 mM DTT and 300 uM peptide substrate, we 
observed DTT “autooxidation” at a rate of 4 ± 0.5 uM/min. A 
fraction of this unspecific redox activity could support the 
observed catalytic activity of 1 uM FGE4C (~ 0.3 uM/min) in 
absence of Cu (I). 
 
 
Figure 3. FGE4C catalyzed insertion of fGly into the N-terminal segment of 
a modified green fluorescent protein (GFP). Product formation was 
monitored by HPLC analysis of trypsin-digested GFP samples (Figures 
S15 & S16).  
 
Finally, we tested whether the 200-fold improved activity of 
FGE4C also applies to protein substrates. To this end we 
produced a green fluorescent protein (GFP) variant featuring 
an N-terminal FGE recognition motif. In an example reaction 
130 uM of this protein substrate was completely converted to 
aldehyde containing product by 1.3 uM FGE4C within less 
than one hour (Figure 3). The observed initial rate (kobs = 7.4 
min-1) is consistent with the catalytic parameters determined 
for the synthetic peptide substrate (Table 1). Given the 
simplicity of this protocol and many published schemes for 
aldehyde specific protein modification,[1, 4a-d, 6]  we anticipate 
that FGE mediated in vitro protein engineering will become a 
widely used methodology. 
 
Conclusions. In this report we showed that addition of one 
equivalent of copper increases the activity of in vitro 
reconstituted FGE by 20-fold and unmasks stereoselective C-
H bond cleavage from the substrate as the rate-limiting step. 
In combination with four point mutations the copper 
supplemented enzyme catalyzes fGly insertion into peptides 
and proteins 200-fold more efficiently than the wild type 
enzymes from T. curvata or M. smegmatis. These 
observations raise the possibility that in vivo FGE activity may 
also depend on a one-electron donating cofactor or partner 
protein that is absent in the purified and crystallized enzymes. 
 
A final note. While this manuscript was under review an 
independent study was published in the Journal of Biological 
Chemisty describing a similar activating effect of copper  on 
FGE from humans and from Streptomyces coelicolor. The 
two studies demonstrate the generality of copper-dependent 
activation of in vitro FGE activity.[16]  
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